Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This is a single-center, single-arm, phase II clinical study to evaluate the efficacy and safety of PD-1 inhibitor combined with cetuximab in neoadjuvant therapy for locally advanced HNSCC.
Epistemonikos ID: 3ba5de1d62ef19b3d93c07ce8da07bda337730b8
First added on: May 15, 2024